Prevention of brown adipose tissue activation in 18F-FDG PET/CT of breast cancer patients receiving neoadjuvant systemic therapy

Journal of Nuclear Medicine Technology

Volumn 38, Issue 1, 2010, Pages 24-27

  Aukema, Tjeerd S ^a   Vogel, Wouter V ^a   Hoefnagel, Cees A ^a   Olmos, Renato A Valdés ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

18FDG; Breast neoplasms; Brown adipose tissue; CT; PET

Indexed keywords

ANTINEOPLASTIC AGENT; DIAZEPAM; FLUORODEOXYGLUCOSE F 18; GLUCOSE; DIAGNOSTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; AUTUMN; AXILLARY LYMPH NODE; BODY MASS; BREAST CANCER; BROWN ADIPOSE TISSUE; CANCER PATIENT; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG MONITORING; DRUG TOLERABILITY; DRUG UPTAKE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMAGE ANALYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY; PREMEDICATION; PROSPECTIVE STUDY; ROOM TEMPERATURE; SCORING SYSTEM; SINGLE DRUG DOSE; SOMNOLENCE; SUBCUTANEOUS FAT; TREATMENT RESPONSE; WINTER; ADJUVANT THERAPY; BREAST TUMOR; CLINICAL TRIAL; COHORT ANALYSIS; DRUG EFFECT; LABORATORY DIAGNOSIS; METABOLISM; METHODOLOGY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOLOGY; SEASON; TEMPERATURE; TRANSPORT AT THE CELLULAR LEVEL;

ADIPOSE TISSUE, BROWN; ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL TRANSPORT; BREAST NEOPLASMS; COHORT STUDIES; DIAZEPAM; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOADJUVANT THERAPY; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; SEASONS; TEMPERATURE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77956640119     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnmt.109.065557     Document Type: Article

References (24)

1. Juweid ME, Cheson BD. Positron-emission tomography and assessment of cancer therapy. N Engl J Med. 2006;354:496-507.
2. Uematsu T, Kasami M, Yuen S. Comparison of FDG PET and MRI for evaluating the tumor extent of breast cancer and the impact of FDG PET on the systemic staging and prognosis of patients who are candidates for breastconserving therapy. Breast Cancer. 2009;16:97-104.
3. Heusner TA, Kuemmel S, Umutlu L, et al. Breast cancer staging in a single session: whole-body PET/CT mammography. J Nucl Med. 2008;49:1215-1222.
4. 18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures. J Clin Oncol. 2008;26:4746-4751.
5. Veronesi U, De Cicco C, Galimberti VE, et al. A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. Ann Oncol. 2007;18:473-478.
6. Barrington SF, Maisey MN. Skeletal muscle uptake of fluorine-18-FDG: effect of oral diazepam. J Nucl Med. 1996;37:1127-1129.
7. Cohade C, Osman M, Pannu HK, Wahl RL. Uptake in supraclavicular area fat ("USA-fat"): description on 18F-FDG PET/CT. J Nucl Med. 2003;44:170-176.
8. Evans KD, Tulloss TA, Hall N. 18FDG uptake in brown fat: potential for false positives. Radiol Technol. 2007;78:361-366.
9. Yeung HW, Grewal RK, Gonen M, Schoder H, Larson SM. Patterns of 18F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET. J Nucl Med. 2003;44:1789-1796.
10. Moura MA, Festuccia WT, Kawashita NH, et al. Brown adipose tissue glyceroneogenesis is activated in rats exposed to cold. Pflugers Arch. 2005;449:463-469.
11. Cohade C, Mourtzikos KA, Wahl RL. "USA-fat": prevalence is related to ambient outdoor temperature-evaluation with 18F-FDG PET/CT. J Nucl Med. 2003;44:1267-1270.
12. Hany TF, Gharehpapagh E, Kamel EM, Buck A, Himms-Hagen J, von Schulthess GK. Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med Mol Imaging. 2002;29:1393-1398.
13. 18F]fluorodeoxyglucose in the neck and upper chest region: are there predictive characteristics? Nucl Med Commun. 2004;25:1109-1111.
14. 18F]FDG uptake in the brown adipose tissue of pediatric and adolescent patients. Pediatr Radiol. 2005;35:984-990.
15. 18FFDG uptake in brown fat can be reduced pharmacologically. J Nucl Med. 2004; 45:1189-1193.
16. Garcia CA, Van Nostrand D, Atkins F, et al. Reduction of brown fat 2-deoxy-2-[F-18]fluoro-D-glucose uptake by controlling environmental temperature prior to positron emission tomography scan. Mol Imaging Biol. 2006;8:24-29.
17. Zukotynski KA, Fahey FH, Laffin S, et al. Constant ambient temperature of 24 degrees C significantly reduces FDG uptake by brown adipose tissue in children scanned during the winter. Eur J Nucl Med Mol Imaging. 2009;36:602-606.
18. Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, et al. Coldactivated brown adipose tissue in healthy men. N Engl J Med. 2009;360:1500-1508.
19. Cypess AM, Lehman S, Williams G, et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med. 2009;360:1509-1517.
20. Parysow O, Mollerach AM, Jager V, Racioppi S, San Roman J, Gerbaudo VH. Low-dose oral propranolol could reduce brown adipose tissue F-18 FDG uptake in patients undergoing PET scans. Clin Nucl Med. 2007;32:351-357.
21. Soderlund V, Larsson SA, Jacobsson H. Reduction of FDG uptake in brown adipose tissue in clinical patients by a single dose of propranolol. Eur J Nucl Med Mol Imaging. 2007;34:1018-1022.
22. Williams G, Kolodny GM. Method for decreasing uptake of 18F-FDG by hypermetabolic brown adipose tissue on PET. AJR. 2008;190:1406-1409.
23. 18F-FDG in brown adipose tissue. J Nucl Med. 2007;48:981-986.
24. 18F-FDG PET/CT scans. Eur J Nucl Med Mol Imaging. 2006;33:785-791.